- Joined
- Mar 16, 2016
- Messages
- 269
- Reaction score
- 143
Last edited:
Thank you for your comments.
However, I’m only interested in hearing from MD/DO psychiatry attendings or residents, not from laypeople, premed students, mid level providers, nurses, administrators, etc.
Thank you for your comments.
However, I’m only interested in hearing from MD/DO psychiatry attendings or residents, not from laypeople, premed students, mid level providers, nurses, administrators, etc.
Thanks for your input?I'm commenting simply because you said this.
<Again not a doctor medical student>I find myself using pregabalin and propranolol for this population. That is, people who have anxious symptoms but don't meet full criteria for MDD or GAD. Adverse effects are generally <<< placebo effects. Plus, there's at least some literature for pregabalin in anxiety disorders.
Edit: I know very well that propranolol has limited systematic evidence. However, many patients demand that I do something and I find it helpful for reducing sympathetic activation (sweating, increased heart rate, etc.).
I said that propranolol has limited evidence. I'm very aware of pregabalin's first line use in Europe per Maudsley.<Again not a doctor medical student>
Why would you describe the effects as placebo and then say there is "some" evidence? Pregabalin is first-line for anxiety in Europe. There must be good evidence.
And the withdrawal from gabapentin/pregabalin has been described as fairly severe.
Either way, I don't see how this is related to the question of enhancement beyond normal baseline, but if I understand correctly, it seems like you use a controlled substance (pregabalin) for cases you deem less severe than those that rise to the level of being diagnostic? I find it all confusing. It's a controlled substance with documented anxiolytic effects, but you make it sound like it pulls less of a punch than an SSRI and that its effects are placebo-like.
I said that propranolol has limited evidence. I'm very aware of pregabalin's first line use in Europe per Maudsley.
What I'm saying is this: people present to my office desiring medication options for symptoms that don't meet DSM criteria. I then offer psychotherapy while also describing pharmacological options, always mentioning the evidence base. Many people want something and accept the risks/benefits of propranolol or pregabalin.
The risks, including whatever withdrawal you describe, are generally much less than those of SSRIs. Never had anyone complain after abruptly stopping propranolol ER 60 mg or pregabalin 50 mg TID.
Some people don't meet DSM criteria and need "enhancement," so that's what I offer.
Someone comes in with social anxiety or excessive worry without the necessary GAD-7 score for GAD and agrees to start psychotherapy? What's the harm in these meds?I mean not gonna lie it’s a little odd though.
This is the “give me antibiotics for my URI” of psychiatry….another option is just say no, come back or we can talk about it when you’ve done 3-4 months of psychotherapy if you’re really so concerned about it. There’s also a difference between a persistent anxiety disorder that doesn’t quite meet GAD criteria vs an adjustment disorder or “doc I get kinda anxious sometimes can you give me a pill for it”.
Also don’t know how you manage to get insurance coverage for pregabalin for “unspecified anxiety d/o” considering I’ve almost never been able to script it without a prior auth or outright rejection.
Do you think that, hypothetically, if someone who does not meet criteria for MDD, GAD, or any other psychiatric disorder started an SSRI, could this confer some benefit to them such as resilience to everyday stresses, increased sociability/confidence, decreased overall neuroticism, or "feeling better than well" as Kramer puts it?
That was the point of that book (and others since then though): Why should psychiatry be different than, say, sports medicine which helps athletes compete at the highest levels, or cosmetic surgery, which (obviously not objectively or quantifiably) enhances aesthetics? The doctors who help Olympics athletes are not helping people who have illnesses. They are performing prevention and interventions that allow them to most safely compete at levels far better than the average human. Why couldn't there be something like that for assisting, say, cancer researchers or pandemic virus researchers perform at higher levels? Obviously the answer is not SSRIs. But stimulants come to mind as a present day solution. This is hypothetical, though, mostly. But if you take the average person and try to improve their state of being you might also find some answers for mental illness along the way. Or it could be that mechanisms that improve other areas of the brain (such as intelligence) better allow a person to cope with a mental illness. People with higher intelligence pre-onset are known to cope with schizophrenia better, for example. You could theoretically find ways to both help the average person increase intelligence that might spill over to help patients with schizophrenia. I'm not sure if there is a lack of interest in enhancing humans cognitively, socially, and morally, or if there's some belief that it's unethical. My personal view is that it's unethical not to pursue any potential avenues that might be open to doing so. I understand that's different than clinical practice today, but that's not really what these books are about.Sounds like this hypothetical person just needs an adult beverage. None of what you describe are psychiatric illnesses, for which psychiatric medications are indicated.
In reality though, anyone who presents to psychiatry for help will likely meet criteria for a diagnosis that requires medication and/or psychotherapy.
I mean, I've seen people describe feeling "better than well" on SRIs, but they were profoundly depressed prior to prescription and their definition of "better than well" is euthymia because they haven't experienced it consistently in a long time.Yeah would just agree that Listening to Prozac is quite dated. Plenty of folks come to my office after being prescribed an SRI for "depression" by a PCP, and just as often as not I deperscribe it and the patient feels better given little to no benefit and significant side effects. I've also never seen an antidepressant make someone feel "better than well," but certainly see plenty of people worse off than before due to anorgasmia or another SRI side effect
So your example is actually (ironically) common folklore. I heard this asked to one of the premier urology fertility specialists in the country and they noted no evidence for increases in energy level/sex drive/mood/muscle building shifting between different levels of normal testosterone. Now supratheraputic levels certainly can do that on a time limited basis and going from below normal to normal will as well but not supplementing in the normal range. Exogenous T, except in people who have a real deficit, is an intervention where risk>>reward.Yeah, I mean, I get that they aren't indicated. They are indicated for psychiatric conditions. I am specifically asking about using them when they are not technically indicated.
Let me give an example using another relatively common treatment: Testosterone replacement therapy. A normal testosterone level in men ranges from 300-1000. Let's say a 40 year old guy has his testosterone levels checked and its 400. Technically he does not have hypogonadism and treatment is not indicated. But I bet if he started TRT and got levels up to 750 or so, he would experience noticeable effects (energy level, sex drive, ability to gain lean mass, mood, etc.) and there are plenty of men who do this. I am essentially asking the same question regarding SSRIs, perhaps even at sub-therapeutic dosages.
This is a psychiatrist....and he sees no potential problems with promoting psychoactive medications as a way of dealing with "life" and a primary way to promote "healthy living?" Really? This book just HAD to have been written in the heart of the "Decade of the Brain" right?! LOL!I recently came an old book, Listening to Prozac by Peter Kramer, and found it interesting and wanted to get some opinions from practicing psychiatrists. Do you think that, hypothetically, if someone who does not meet criteria for MDD, GAD, or any other psychiatric disorder started an SSRI, could this confer some benefit to them such as resilience to everyday stresses, increased sociability/confidence, decreased overall neuroticism, or "feeling better than well" as Kramer puts it? Are there any studies or anecdotes on this? Thanks
Why did you read this book?I would say his idea came from his own clinical experience which is why he wrote the book.
Why did you read this book?
No one seemed to enjoy the topic.It's a pretty famous book written by a very well known psychiatrist...
Also why the deletion of the OP and literally every one of your answers in this thread OP?
You've just described a solid 25% of my day.I'll say that the setting you probably see this the most actually is primary care. People come in, score high on a GAD-7 or PHQ-9 or something or come in like "doc I'm feeling depressed"...bam here's some Lexapro. So there's probably more people than we think out there who don't actually meet MDD criteria who get put on an SSRI for "depression".
Muscle building is pretty much the only benefit for persons without real deficiency who take exogenous TSo your example is actually (ironically) common folklore. I heard this asked to one of the premier urology fertility specialists in the country and they noted no evidence for increases in energy level/sex drive/mood/muscle building shifting between different levels of normal testosterone. Now supratheraputic levels certainly can do that on a time limited basis and going from below normal to normal will as well but not supplementing in the normal range. Exogenous T, except in people who have a real deficit, is an intervention where risk>>reward.